Results

Total Results: 1,217 records

Showing results for "description".

1021. Disposition of Comments Report for Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
      May 29, 2013 - I believe this should either be excluded as an "outcome" or the results embedded within a nuanced description … We share some of the reviewers concern regarding the description of filter related thrombosis. … Despite these concerns we believe that such outcomes should be included with a nuanced description … We agree with the authors Reviewer 17 Results excellent description of studies Thanks Public Comments

1022. Disposition of Comments Report for Pressure Ulcer Risk Assessment and Prevention (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
      May 08, 2013 - Peer Reviewer #2 Results Page 32, last paragraph: It would be preferable to drop the description … In the description of the Inman et al. trial, “95%” is missing from the “results” column. … We revised the description of pressure ulcers to "stages" using the 2009 NPUAP/EPUAP guidelines. … We revised the description of pressure ulcers to "stages" using the 2009 NPUAP/EPUAP guidelines. … "Powered/nonpowered" in Table 6 is a description of the type of support surface (i.e. a powered or

1023. FRN 35 - Preventive Pharmacological Treatments for Migraine in Adults: Future Research Needs (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
      April 01, 2013 - Considerations RCT Design Description Individual patients randomly assigned to preventive pharmacologic … Considerations Interrupted Time Series (Without a Comparison Group) Design Description A cohort of … Considerations RCT Design Description Individual patients randomly assigned to either multimodal … Considerations RCT Design Description Individual patients randomly assigned to either combination … Considerations Interrupted Time Series (Without a Comparison Group) Design Description A group of

1024. Assessing Applicability (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
      January 01, 2009 - Applicability Summary Table Template Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table Domain Description of Applicability Evidence for a Key Question … angiotensin-converting enzyme; NYHA = New York Heart Association Comparison Strength of Evidence Conclusions With Description

1025. Executive Summary: Pain Management Interventions for Hip Fracture (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
      May 01, 2011 - Data Analysis Evidence tables and qualitative description of results were presented for all included … Results Description of Included Studies The search strategy identified 9,357 citations; 83 unique … The most common sources of potential bias were inadequate description of the randomization procedure

1026. Methods Guide Atkins (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
      January 01, 2011 - Elements to be included in a summary table characterizing the applicability of a body of studies Domain Description … Example summary table characterizing the applicability of a body of studies Domain Description of applicability … Example summary table for body of evidence Comparison Strength of Evidence Conclusions with description

1027. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
      March 29, 2011 - participant characteristics (age, diagnosis, symptom severity, etc.), intervention characteristics (description … author, year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1028. S29 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
      October 01, 2007 - Vignettes were used to provide all interviewees with a common point of refer- ence13,14 and a “listenable” description … intended to provide quantitative data; rather, they were intended to provide a thorough and accurate description … Potential Barriers Major Themes Description Impact on satisfaction Members, physicians, formulary committee

1029. Assessing Applicability (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
      January 01, 2009 - Applicability Summary Table Template Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table Domain Description of Applicability Evidence for a Key Question … angiotensin-converting enzyme; NYHA = New York Heart Association Comparison Strength of Evidence Conclusions With Description

1030. Methods-Guidance-Applicability Methods (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
      January 01, 2011 - Elements to be included in a summary table characterizing the applicability of a body of studies Domain Description … Example summary table characterizing the applicability of a body of studies Domain Description of applicability … Example summary table for body of evidence Comparison Strength of Evidence Conclusions with description

1031. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
      January 01, 2010 - author, year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1032. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
      December 09, 2009 - author, year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1033. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
      May 24, 2010 - held concepts of high quality including the following: a formal randomized controlled study; clear description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1034. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
      April 06, 2010 - criteria: (1) appropriateness of the randomization scheme, (2) appropriateness of the blinding, and (3) description … concepts of high quality, including the following: a formal randomized controlled design; a clear description

1035. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
      June 01, 2010 - contain some common elements (e.g., author, publication year, study location, time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1036. Suppl-2-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
      January 01, 2011 - The supplement concludes with a description of how Directed Acyclic Graphs (DAGs) can be used to select … The supplement concludes with a description of how Directed Acyclic Graphs (DAGs) can be used to select

1037. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
      January 27, 2014 - Peer Reviewer#1 Introduction The description needs to be clarified regarding the clinical indications … Peer Reviewer#1 Methods There is no description of whether or not the authors included grey literature … Peer Reviewer#1 Methods Within the description of the data synthesis methods the authors need to justify … An explanation of how pain was evaluated is included in each study description.

1038. Colorectal-Surgery-Preparation Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-surgery-preparation_research-protocol.pdf
      March 26, 2013 - Please see the preceding section for a detailed description of the populations, interventions, and outcomes … features: lowest likelihood of confounding due to comparison to a randomized controlled group; a clear description … In the event of protocol amendments, the date of each amendment will be accompanied by a description

1039. Disposition of Comments Report for Procalcitonin-Guides Antibiotic Therapy (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
      October 05, 2012 - However, when we read a submitted version of this paper we found their description of the intervention

1040. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
      March 07, 2012 - None of the studies looked specifically at children with joint swelling; we added this to the description … operating characteristic curve for different tests and diagnoses could be improved with a detailed figure description … We have reworded the outcome description for KQ5.